Sanofi New Liabilities Contingent Liabilities Recognised In Business Combination
Sanofi (SNY) reported New Liabilities Contingent Liabilities Recognised In Business Combination of EUR 51.00 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-02-17.
Financial Statements › Notes
ifrs-full:NewLiabilitiesContingentLiabilitiesRecognisedInBusinessCombination · last filed 2026-02-17
| Period end | New Liabilities Contingent Liabilities Recognised In Business Combination 6 month | New Liabilities Contingent Liabilities Recognised In Business Combination 12 month |
|---|---|---|
| 2025-12-31 | 51.00M EUR 20-F · filed 2026-02-17 | |
| 2024-12-31 | 0.00 EUR 20-F · filed 2026-02-17 | |
| 2023-12-31 | 0.00 EUR 20-F · filed 2026-02-17 | |
| 2022-12-31 | 156.00M EUR 20-F · filed 2025-02-13 | |
| 2022-06-30 | 158.00M EUR 6-K · filed 2022-07-28 | |
| 2021-12-31 | 360.00M EUR 20-F · filed 2024-02-23 | |
| 2021-06-30 | 17.00M EUR 6-K · filed 2021-07-29 | |
| 2020-12-31 | 360.00M EUR 20-F · filed 2022-02-23 | |
| 2018-12-31 | 228.00M EUR 20-F · filed 2021-03-04 | |
| 2017-12-31 | 85.00M EUR 20-F · filed 2020-03-05 | |
| 2016-12-31 | 354.00M EUR 20-F · filed 2019-03-08 |